Research and practice in thrombosis and haemostasis · 2026
Platelet FcγRIIA is dispensable for hemostasis and arterial thrombosis in the absence of FcγRIIA-specific extracellular stimuli.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Tupin Florian, Magnenat Stephanie, Mouriaux Clarisse, Mangin Pierre H, Hechler Béatrice
Аннотация
BACKGROUND: FcγRIIA, a high-affinity receptor for immunoglobulin G immune complexes with no ortholog in mice, has a prominent role in host defense against pathogens via immune cell activation. A role for platelet FcγRIIA in enhancing thrombosis was suggested, involving interplay between αIIbβ3 integrin and FcγRIIA, without requiring FcγRIIA-specific extracellular stimuli. Recent data challenged this view, showing that FcγRIIA inhibition neither impaired platelet spreading on fibrinogen nor prevented thrombus growth and stability under flow.
OBJECTIVES: This study assessed contribution of FcγRIIA to platelet function and experimental hemostasis and thrombosis without FcγRIIA-specific trigger.
METHODS: The role of FcγRIIA in platelet functions was evaluated using washed human platelets following blockade of FcγRIIA with the monoclonal antibody IV.3, and transgenic mice expressing human FcγRIIA (FcγRIIA+) when compared with wild-type (WT) mice. The importance of FcγRIIA in hemostasis and arterial thrombosis was assessed using a tail vein transection bleeding model and various thrombosis models with real-time intravital microscopy, respectively.
RESULTS: Aggregation of washed human platelets to various agonists was identical in the absence or presence of IV.3, as was aggregation of washed WT and FcγRIIA+ platelets. Adhesive and aggregation properties of FcγRIIA+ and WT platelets were identical when perfused over collagen under flow. FcγRIIA+ and WT mice exhibited similar tail bleeding time and kinetic and extent of thrombus formation in various arterial thrombosis models.
CONCLUSION: FcγRIIA does not contribute to platelet functions during hemostasis and arterial thrombosis in the absence of FcγRIIA-specific extracellular stimulation, which does not support a role for FcγRIIA in amplifying outside-in αIIbβ3 signaling.
OBJECTIVES: This study assessed contribution of FcγRIIA to platelet function and experimental hemostasis and thrombosis without FcγRIIA-specific trigger.
METHODS: The role of FcγRIIA in platelet functions was evaluated using washed human platelets following blockade of FcγRIIA with the monoclonal antibody IV.3, and transgenic mice expressing human FcγRIIA (FcγRIIA+) when compared with wild-type (WT) mice. The importance of FcγRIIA in hemostasis and arterial thrombosis was assessed using a tail vein transection bleeding model and various thrombosis models with real-time intravital microscopy, respectively.
RESULTS: Aggregation of washed human platelets to various agonists was identical in the absence or presence of IV.3, as was aggregation of washed WT and FcγRIIA+ platelets. Adhesive and aggregation properties of FcγRIIA+ and WT platelets were identical when perfused over collagen under flow. FcγRIIA+ and WT mice exhibited similar tail bleeding time and kinetic and extent of thrombus formation in various arterial thrombosis models.
CONCLUSION: FcγRIIA does not contribute to platelet functions during hemostasis and arterial thrombosis in the absence of FcγRIIA-specific extracellular stimulation, which does not support a role for FcγRIIA in amplifying outside-in αIIbβ3 signaling.